a rclruspectlie arwl!sos of 35 1 shon clularcn ubs u n d~n~c n t y r o u h hormone IhGII) tc\tlng \nth 1nsul.n induced h).pogl)ccmw and a~p.n~nc bctuwn 7/75 ana 6\92 A \ c n s~s ~t h e t c r nas p l n d (pain SI I I I I UI US) 30 W 60 I NI I UI CS prlnr to the ICS! At 8 a m h e fatm): ch.ld received insulin, .05 to . I unit/kg, (.1 glucose stimulus) A serum cortisol was m&ured followng ain at 8 a m and follouing insulin at 9 a m Children were judged to have an adequate !glucose stimulus ifthc blood sugar fell 40% and or reached a glucose nadir i 45 mg/dl Of the ch~ldrcn with an adquatc &glucose stimulus, 102 were hGH deficient (hGH 5 7 ng/ml), * Terminal aldosterone biosynthesis (TAB) from 1 l-deoxycorticosterone (DOC) requires ll-hydroxylatton, 18-hydroxylation, and finally oxidation at C-18. One angle P450 catalyzes all 3 steps encoded by the gene CYPllB2. The two known TAB defects are characterized by excess corticosterone (B) and deficient Aldo. CMO (corticosterone methyl oxidase deficiency) type I has low, while CMO II has elevated 18-OHB levels. Since 1982, we diagnosed 3 pts with CMO I and 5 with CMO II by multisterotd analysis (RIA after extraction and automated gel chromatography). Both types could be clearly differentiated by B118-OHB and 18-OHBI Aldo ratios which ranged 32-136 and 11.5-16.7 in CMO I, and 1.9-11.2 and 22-286 in CMO II pts, respectively. The ratio BI18-OHB appears particularly useful in CMO cases w~t h undetectably low Aldo levels and noncalculable 18-OHBIAldo ratios. In 2 of our 5 CMO II pts we did not lind any of the 2 known mutations described in such pts from Iranian-Jewish origin. Genomic cloning and sequence analysis of the CYP11B2 genes in our CMO I and II pts may reveal the nature of the marked biochemical differences found in TAB dtsorders.
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D e p a r t m e n t s o f P e d i a t r i c s . U n i v . P a r n a C A u t o n o m o u s B a r c e l o n a -I t a l y C S p a i n . t h e l r p i t v l t a r y a n d o v a r i a n f u n i t l o n i we a r i e i i e d t h e g o n a d o t r a p i n e a n d o v a r i a n s t o r o l d r e s p o n s e t o t h e a d m i n i s t r a t i o n a f 5 0 0 ug S . C . o f GnRHa L e u p r o l i d e a c e t a t e i n 1 p a t i e n t s w i t h IDDM ( a g e 1 1 . 8 * 1 . 7 y r s ) a n d I 2 a g e -m a t c h e d n o r m a l g i r l s . B a s a l and s t i m u l a t e d Lli, I S H , f 2 . D t A S , 1 a n d b a s a l l1OHP a n d DL-A i e v e l s " e r e r~m i l a r i n t h e t u o g r o u p s , r e g a r d l e s s o f e l e v a t e d b a r e l i n e androgens l e v e l s i n f e u g i r l s .
2 L h r -s t i m u l a t e d I l O H P l e v e l s u e r e . s i g n~f i i a n t l y h i g h e r i n p a t i e n t s t h a n i n c o n t r o l s (7.Br2.2 v r . 2.8.0.3 n H o l l 1 , p 0 . 0 0 0 1 ) . DL-A r e s p o n s e s w e r e a l r o higher t h a n i n c o n t r o l s a l t h o u g h t h e d i f f a r e r m r e war n o t r t a t i i t i i a l l y i i g n~f i c a n t 19.8+1.4 v s .
. 1 + 0 . 1 n M o l I l n . r . ) . I h l r b e h a v i u u r war i~m~l a r t o t h a t o f a p r e v i o u s l y s t u d i e d -g r o u p o f 3 5 a d o l e s c e n t s u l t h h i r i u t i i m a n d ovarian h y p e r f u n c t i o n ( I
T h e s e d a t a d e m o n s t r a t e t h e p r e s e n c e o f a h i g h i n r l d e n i a o f o v a r l a n h y p e r f u n c t i o n i n a d o l e s c e n t d i a b e t i c g i r l s w h i t ) c a n u n d e r l i e t h e m e n s t r u a l d l r o r d e r r . We n e e d a f o l l o w -u p o f t h e s e p a t l e n t i t o c l a r i f y u h e t h e r t h e y w i l l d e v e l o p a c l e a r h y p e r a n d r o g e n i s m , a s s u g g e s t e d by o u r r e s u l t s , o r a p a r t i a l gonadotropin l n r u f f i c i e n r y a s o t h e r o b s e r v e d I n a l d e r d~a b e t i c p a t i e n t s .
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GONADAL hel long term follow-up of pallents after bone marrow transplantation (BMT) allows for a more preclse def~nttlon of 11s potential s~de-effects Gonadal funct~ons are potenttally sensltlve to several procedures regularly used for BMT preparatlons, either total body lrrad~afion (TBI) or hlgh dose regcmen chemotherapy We present a serles of 24 patlents aged at least 14 years prevfously treated by BMT, elther before or atler onset 01 puberly There were 17 boys and 7 glrls Mean age at BMT was 13.2 for the boys and 11.2 for the girls. 11 d~d not show any slgn of pubertal development at the time of BMT The indications for BMT were ALL In 11, ANLL In 2, lymphoma In 4. Chronic leukernla in 1, aplastlc anaemla In 4 and solld tumors in 1 13 recelved allogenlc BMT and 11 autologous BMT. All the 7 glrls, whatever the types of preparatlons and BMT. developed severe ovarlan fallure 01 the 17 boys, all 5 who have received previously testlcular irrad~at~on for ALL relapse and TBI before BMT have evidences of leydqan dysfunct~on (A) The evolution of the others 12 IS summarlzed in the (GKD) and myopathy. The relationship between theee c o n d~t i o n s is genetlc srnce the loci for CAH, HH and GKH are located in the same reglon of X chromoeome. A progressive high frequency hearing loss (HL) has been recently described only by Zachmann. We report two male cousins [aged 24.2 and 21.7 yre at last observation) with CAH, HH and an unusual tall stature. GKD was excluded by d e t e r m r n a t~o n of plasma and urine glycerol level-. A mild bilateral HL for hlgh frequencles was dragnosed in the younger patient at 15 yrs of age. At thls tlme the audlogram of the older patient was normal.The hearing evaluatron performe3 In the following years showed a progrension o f the HI, most evldent at 4KHr in the younger patlent and a cochlear s~t e of leeron was revealed by brainstem response audiometry. I n t h e older patlent, the last audiogram showed juet a sllght aeymmetrkc seneorineural HL for the hrgh frequencles (2-8 KHr). In agreement wlth Zachmann'B report, our data show that HL may be aesocrated wlth CAH and HH even if the degree o f HL ie unpredictable.Therefore the hearing function of these patlents must be monitored.The hypotheals of a genetic basis of the relationehip between CAH,HH and H L ( v r c l n~t y of the locus of X-linked deafness with the loci of CAH and HH) ia faahinating and requlrea further support.
